The Times of India
New Delhi
Joined June 2012
- Tweets6.1K
- Following596
- Followers1.7K
- Likes3.1K
Govt spends more than Rs 2 lakh crore annually on the subsidised urea, some suspected to be going out of country..
1
38
pradeep thakur retweeted
CPI(Maoist) boss and its central military commission chief Thippiri Thirupathi @ Deoji to TOI:
‘We have not surrendered to lead a comfortable personal life. We want to take up people’s issues through legal means. We will now engage in people’s politics as part of our open and lawful struggle for an exploitation-free society’
timesofindia.indiatimes.com/…
A projected investment of Rs 50 lakh crore in power sector by 2032, Rs 3 lakh crore to flow from Central govt; CAG asked to look for gaps..
timesofindia.indiatimes.com/…
1
52
pradeep thakur retweeted
India adds 9,783 postgraduate medical seats for 2026-27, taking the total PG intake to 68,305 from 58,522.
Government medical colleges account for the largest share of the expansion, with 4,373 new seats, followed by private colleges (4,148) and deemed universities (1,262). @timesofindia @NMC_BHARAT @MoHFW_INDIA
#MedicalEducation #NEETPG #NMC
ED finds more foreign entities like Neville Roy Singham funding ultra-Left, anti-govt activities in India. A German trust, a law firm in the US and shell entities in tax havens, money trail revealed layering of transactions through many jurisdictions..
3
67
pradeep thakur retweeted
Cough lingering weeks after an infection? Antibiotics may not help. Airway inflammation, pollution, allergies, asthma or acid reflux could be to blame. Repeated antibiotic use without finding the cause can do more harm than good. Here’s what doctors say you should do. @timesofindia @gckhil
#Cough #AirPollution #AntibioticResistance
American Justice and Education Fund was paying NewsClick to upload material on an online platform Peoples Dispatch. ED questions the axis that was involved in a propaganda war against the US, India and behind much of the anarchy in Europe today!
timesofindia.indiatimes.com/…
66
pradeep thakur retweeted
Hospitals charging patients inflated prices for medicines and consumables is not just unfair, it can push families into financial distress when they are already dealing with a medical crisis. The Centre’s admission before the Supreme Court must translate into concrete action, transparent pricing and accountability. Patients cannot be made to pay for unchecked profiteering.
#Healthcare #PatientRights #HealthForAll @MoHFW_INDIA
pradeep thakur retweeted
40 years on things haven’t changed. Govt still has to push businesses to export! @ficci_india @CIIEvents
This is what Department of Justice is doing in Union Law Ministry with case pendency in courts touching 6 crore.
From messy roadside trimmings to a clean path!
Check out the before & after transformation at #DepartmentOfJustice as the Department leads the change at Jaisalmer House, New Delhi for #SpecialCampaign6.
Swachhata in full swing.
#SwachhBharat #CleanIndia
First time in India, probably, FSSAI has labeled a branded product like Nestle ‘unsafe’, that’s unacceptable!!
Nestlé’s Low Fat Dairy Whitener has been declared “unsafe and substandard” by FSSAI after a sample collected from The Lalit, Connaught Place, Delhi, failed laboratory analysis. Nestlé India, however, said the product is safe and complies with all applicable food safety standards. It said the company has conducted extensive testing of the product and found it compliant with regulatory requirements. #FSSAI #Nestle #FoodSafety #DairyWhitener #FoodSafetyIndia #Delhi #FoodStandards
pradeep thakur retweeted
Nestlé’s Low Fat Dairy Whitener has been declared “unsafe and substandard” by FSSAI after a sample collected from The Lalit, Connaught Place, Delhi, failed laboratory analysis. Nestlé India, however, said the product is safe and complies with all applicable food safety standards. It said the company has conducted extensive testing of the product and found it compliant with regulatory requirements. #FSSAI #Nestle #FoodSafety #DairyWhitener #FoodSafetyIndia #Delhi #FoodStandards
pradeep thakur retweeted
FSSAI suspends the licence of Seven Seas Hospitality Pvt Ltd with immediate effect following serious food safety violations found during inspection.
Inspectors reported poor hygiene, fungal growth on food items, degraded cooking oil, improper meat storage, refrigeration issues and pest infestation. Around 74 kg/litres of non-compliant food was destroyed. The FBO scored just 30% for compliance. #FSSAI #FoodSafety @timesofindia
pradeep thakur retweeted
Centre admits before SC the problem of patients being fleeced by hospitals and medicine shops because of exorbitant pricing of drugs, assures to fix it, Court grants govt time till Sept 12 to do it.
pradeep thakur retweeted
Exorbitant pricing of medicine: SC says its a broad daylight dacoity & extortion from patients and govt's silence is surprising.
Big chain hospitals don’t accept CGHS patients, even military veterans having ECHS are not admitted when in emergency. None of them recognize Ayushman Bharat! Regulatory mechanism is non-existent or just on paper!
पैसों की कमी से अब नहीं रुकेगा इलाज! 🩺🏥
आयुष्मान भारत योजना (PM-JAY) ने 8 सालों में देशवासियों को इलाज के भारी खर्च से मुक्ति दिलाई है। अब अपनों के इलाज के लिए न घर गिरवी रखना पड़ता है और न ही खेत बेचना पड़ता है।
🔹 60+ करोड़ लोगों को ₹5 लाख तक का मुफ्त इलाज।
🔹 38,000+ अस्पतालों में बिना पैसे दिए इलाज की सुविधा।
🔹 13+ करोड़ मरीजों का इलाज और ₹2 लाख करोड़ की बचत।
आयुष्मान कार्ड है स्वस्थ परिवार की सच्ची गारंटी! 🛡️👨👩👧👦
#SevaSankalpAbhiyan
#8YearsOfAyushmanBharat
pradeep thakur retweeted
Hospitals could be charging patients up to 2,841% more for commonly used #medical #consumables, with major price gaps reported between procurement costs and patient billing. Maha FDA chief has urged the Centre to address this “permissible gap” and ensure greater transparency in hospital pricing. #Healthcare #MedicalCosts #India @Rupalijee @timesofindia @MoHFW_INDIA @JPNadda
A life saving drug selling at ₹3200 within corporate hospitals and at ₹1200 just outside their gates. No surprise “an IV infusion set of ₹11.05 sold for ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20…” @Pharmadept & regulators missing!
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
moneycontrol.com/news/busine…
